Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400579 · ClinicalTrials.gov registry record · NA
A Study of the Feasibility of Prehospital Remote Ischemic Conditioning
A NA study of Chest Pain, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03400579: Completed NA study of Chest Pain, sponsored by University of North Carolina, Chapel Hill.
NCT03400579 is a NA study of Chest Pain that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 10 participants, below the 1,458-participant average among 22 other Chest Pain trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03400579, a NA study of Chest Pain, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital setting. Eligible patients will have chest pain or anginal equivalent symptoms and require ground ambulance transport to the hospital. All subjects will undergo the standard RIC procedure (i.e., up to four cycles of alternating 5-min inflation and 5-min deflation) with the autoRIC® device (CellAegis Devices, Inc., Toronto, Ontario). The primary objective is to evaluate the number of cycles of RIC completed in patients having the procedure initiated by EMS in the prehospital setting.
Primary Outcome
A completed RIC cycle without interruption is defined as 5 minutes inflation followed by 5 minutes deflation for a total of 10 minutes.
Conditions Studied
Interventions
- DEVICE autoRIC® device
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-10 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
What the finished NCT03400579 record still lists
NCT03400579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,458-participant average among 22 other Chest Pain trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chest Pain appearing as the primary indexed condition, and to 1 intervention - of which autoRIC® device is the first listed.
NCT03400579 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03400579 about?
NCT03400579 is a clinical study titled "A Study of the Feasibility of Prehospital Remote Ischemic Conditioning". Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital setting. Eligible patients will have chest pain or anginal equivalent symptoms and require ground ambulance transport ...
What is the current status of trial NCT03400579?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-10. Estimated completion is 2019-10-01.
What conditions does trial NCT03400579 study?
This clinical trial studies the following conditions: Chest Pain.
What interventions are being tested in trial NCT03400579?
The interventions under investigation include: autoRIC® device (DEVICE).
Who is sponsoring clinical trial NCT03400579?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400579 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chest Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03400579's enrollment target sits among peer trials
10 21st of 22 higher than 1 of 22 other Chest Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chest Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality for Non-cardiac Chest Pain
RECRUITING · NA
-
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
RECRUITING · NA
-
Intraoperative Echocardiography in Low-Risk CABG Surgery
ACTIVE NOT RECRUITING · NA
-
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
ACTIVE NOT RECRUITING · NA
-
Comparing Sports Bra Design in Full Busted Women
COMPLETED · NA
-
Chest Pain Perception and Capsaicin Sensitivity
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI